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Abstract
Background: In recognition of the need for long-term planning for global health research, and to inform future
global health research priorities, the United Kingdom Department for International Development (DfID) carried out
a public consultation between May and June 2015. The consultation aimed to elicit views on the (1) the long-term
future global health research priorities; (2) areas likely to be less important over time; (3) how to improve research
uptake in low-income countries; and (4) how to build research capacity in low-income countries.
Methods: An online consultation was used to survey a wide range of participants on global health research
priorities. The qualitative data was analysed using a thematic analysis, with frequency of codes in responses
tabulated to approximate relative importance of themes and sub-themes.
Results: The public consultation yielded 421 responses. The survey responses confirmed the growing importance
of non-communicable disease as a global health research priority, being placed above infectious diseases.
Participants felt that the key area for reducing funding prioritisation was infectious diseases. The involvement of
policymakers and other key stakeholders was seen as critical to drive research uptake, as was collaboration and
partnership. Several methods to build research capacity in low-income countries were described, including
capacity building educational programmes, mentorship programmes and research institution collaboration and
partnership.
Conclusions: The outcomes from this consultation survey provide valuable insights into how DfID
stakeholders prioritise research. The outcomes from this survey were reviewed alongside other elements of a
wider DfID consultation process to help inform long-term research prioritisation of global health research.
There are limitations in this approach; the opportunistic nature of the survey’s dissemination means the
findings presented may not be representative of the full range of stakeholders or views.
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Background
Since the development of the millennium development
goals there have been large improvements in the health of
the poorest countries in the world, with reductions in
child mortality, new HIV infections, and deaths from mal-
aria and tuberculosis, among others [1]. The epidemiology
behind the burden of disease is changing as advances are
made in dealing with some of the infectious diseases of
poverty [2]. These changes are creating new challenges for
donor and recipient countries in how to best invest
resources to have the greatest impact on health globally
and locally [3, 4]. The Global Goals maintain a focus on
important infectious diseases, which still account for the
majority of the burden of disease in low-income countries,
but also acknowledges the growing importance of other
emerging health challenges [4].
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Health research is a key tool to deliver change
which positively impacts the lives of the poorest, en-
abling policymakers and practitioners to do more with
less resources [5, 6]. To ensure the greatest health
impact, it is essential that health research funding
priorities and approaches reflect the existing and
emerging global health threats to achieve the Global
Goals.
While the vast majority of burden of disease globally
is based in developing countries, only a small proportion
of health research funding is invested in programmes for
the benefit of these countries [5]. In recognition of the
critical role of research in tackling the determinants of
excess mortality and morbidity in low- and middle-
income countries, WHO has called on countries to fund
research aimed specifically at diseases that affect people
in developing countries [7].
The United Kingdom Department for International
Development (DfID) supports the importance of invest-
ment in research as a key enabler of development, and is
the second largest government supporter of product
development research [8]. In recognition of the need for
long-term planning for funding health research for
development and to inform future global health research
priorities, DfID carried out a public consultation be-
tween May and June 2015. The consultation aimed to
elicit views on (1) the long-term future global health re-
search priorities; (2) areas likely to be less important
over time; (3) how to improve research uptake in low-




Participants were recruited to the consultation survey
using established health research networks and social
media. Links to the online survey were tweeted from the
DfID twitter feed, posted on the DfID website, and
current DfID research funding recipients were emailed
the survey link. All correspondence encouraged wide
sharing of the survey link.
The survey was open for a period of 4 weeks from late
May 2015.
Data collection
Data were collected via Survey Monkey, an online
survey tool. Responses to questions were free text, to
allow respondents the flexibility to provide a wide range
of replies to each question, without being limited to a
closed selection of answers. The questions covered the
key topic areas of long-term future research priorities,
health research areas of reducing priority, research
uptake and health research capacity building. For the
list of questions, please see Box 1.
Box 1 Consultation survey questions
Respondents were also asked for information regard-
ing their professional affiliation, place of residency (high,
middle or low income), and years of relevant work or
research experience.
Participation in the survey was voluntary. Individual
responses to each question were collated to assure
anonymity in data presentation. The only identifiable
participant detail taken as part of the survey was their
email address (entry was voluntary), which was not
linked to survey responses.
Data analysis
Data were analysed using a thematic analysis, focussing
on categories of response provided by consultation re-
sponders. The data analysis followed three steps, namely
familiarisation with consultation survey responses for
individual questions; development of interpretative codes
for individual question responses to build a coding
framework; and categorisation of codes into themes and
subthemes [9].
The analysis also included a tabulation of the fre-
quency of each code from survey responses, to generate
an approximation of relative importance of themes and
sub-themes within the data.
This consultation process was part of a wider consult-
ation, which also included a health research expert
panel, internal DfID health adviser consultation, and
Delphi study with expert informants. The outcomes
from the consultation exercises were used to inform
long-term health research priorities for DfID.
Results
Results overview
The public consultation survey yielded 421 responses.
The largest proportion of respondents came from aca-
demia (43%), which was nearly double the next largest
sector, non-governmental organisations (23%). Other re-
spondents came from international organisations (13%),
national government (9%) and industry (3%). The major-
ity of respondents came from high-income countries
(60%), with 40% from low- or middle-income countries.
The relevant experience of respondents ranged from less
than 1 year to 50 years, with a modal category of 10 to
15 years of experience.
What do you think will be the top three priority areas for global health
research for the next 20–50 years?
What areas do you think will be less important than today?
In your view, what are the best ways to improve research uptake in low-
income countries to get research into policy and practice?
In your view, what are the best ways to build health research capacity in
low-income countries?
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What do you think will be the top three priority areas for
global health research for the next 20–50 years?
The strongest theme to emerge from the survey responses
is the growing importance of non-communicable diseases
(NCD). This theme had substantially higher frequency of
comment than any other area. The overwhelming focus of
responses related to NCD risk factors were on obesity (60
comments), with other risk factors (e.g. diet, hypertension,
tobacco and alcohol) receiving lower proportions of
responses (no category with a higher frequency than 10
comments). The most frequently mentioned NCDs were
cancer (32 comments), diabetes (27 comments), and
dementia/neurological conditions (24 comments).
“Research to inform strategies and policies to prevent
and treat non-communicable diseases”
“Infectious diseases will continue to be a top priority
in global health research, especially the ‘big three’:
HIV, TB, and malaria. These diseases remain top
killers across the world, and new tools are still
urgently needed to curb these epidemics.” Quotes from
participants on long-term future priority areas
While respondents on the whole cited NCDs as the
most important research priority, many acknowledge the
continuing importance of infectious diseases. The
frequency at which NCDs were mentioned compared to
infectious diseases possibly reflects the increasing preva-
lence of NCDs and their associated burden of disease in
poor populations, as well as the progress made in infec-
tious disease research during the past decade. Many of
the participants referenced infectious diseases as a gen-
eral category. However, the majority of comments fo-
cused on individual diseases, with three subthemes
sharing approximately equal frequency; HIV, malaria and
emerging diseases.
Other strong themes identified by participants for fu-
ture research prioritisation include nutrition/malnutri-
tion (114 comments), health systems (95 comments),
and maternal, neonatal and child health (79 comments).
What areas do you think will be less important than
today?
There were six times more comments for infectious
diseases than any other theme. Within the infectious
disease theme, most comments were about specific in-
fectious diseases, with 69 comments for HIV and 32
comments for malaria. There were 39 comments for
HIV in the first question (about future priority areas),
which possibly reflects recognition of the progress made
in HIV and substantial research funding in this area rela-
tive to other global health issues. Other themes
highlighted were reproductive, maternal, newborn and
child health, NCDs, nutrition and vertical programmes,
although all received relatively few comments in com-
parison to infectious diseases.
“Some of the communicable diseases that have been
the greatest priorities over the last 15 years including
HIV and malaria may well become less significant in
terms of premature death as NCDs … become major
causes of death and disability.” Quote from
participant on areas for reducing future importance
What are the best ways to improve research uptake in
low-income countries to get more research into policy
and practice?
The involvement of policymakers and other key stake-
holders in research processes was highlighted as import-
ant to improve research uptake (44 comments). Responses
encouraged the early engagement of these groups in the
selection of research topics and research approaches.
Responses also highlighted the need for continued in-
volvement throughout the research process and into the
integration of findings into policy and practice.
The role of collaboration and partnership for evidence
uptake was a very strong theme (82 comments), includ-
ing the importance of collaboration with in-country bod-
ies to integrate evidence into their policy and practice.
Research funding as a mechanism to drive evidence up-
take was highlighted by participants as a strong driver
(63 comments), including research funding criteria on
integration of evidence into policy and practice.
“Embed research into existing [government] health
programmes so that research addresses national
priorities, government has ownership, and research
is real-life, leading to real-life answers that are
appropriate for the context.” Quote from participant
on how to improve research uptake
Participants also identified key themes for evidence
uptake such as education and training aimed at policy-
makers and researchers, and targeted dissemination of
research findings to decision-makers.
What is the best way to build research capacity in low-
income countries?
Informants emphasised the importance of programmes
to build researcher capacity (132 comments), including
degree or master’s programmes, PhD or post doc pro-
grammes, or research scholarships. Within this theme,
there was also support for mentorship programmes
aimed at early career researchers, with particular atten-
tion given to North–South mentorship programmes.
Collaboration and partnership was also a strong theme
(115 comments), focusing principally on North–South
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research institution collaboration, although there was
also notable support for South–South collaborations to
build regional capacity.
“Build local capacity for research in low-income coun-
tries through North–South research collaborations and
exchange of research competencies and best practices.”
Quote from participant on how to improve research
uptake
The importance of stipulating the inclusion of cap-
acity building as part of the funding decision making
was highlighted. Participants also noted the need for re-
searchers to integrate research capacity building into
their research design, so that they ensure a lasting leg-
acy beyond programme completion. Capacity building
can extend beyond researcher capacity to include in-
country policymakers and programme managers. Core
to success under this approach is developing research
funding opportunities which respond to in-country
need, and are more likely to be engaged with by in-
country stakeholders.
Investment in the research infrastructure (64 com-
ments), particularly in low-income country research
institutions, was also seen as a key method to develop
capacity.
Discussion
DfID used this public survey as part of a wider con-
sultation exercise, which included internal and exter-
nal sources of feedback, and comprising a Delphi
survey of infectious disease experts [10]. The wider
process enabled targeted feedback to be combined
with the public-facing open access nature of the pub-
lic consultation. The outcomes of this process were
subject to external peer review to validate DfID’s fu-
ture health research priorities [11]. The approach, of
multisource feedback to aid prioritisation of research
funding, has the advantage of including a broad set of
views, which can be used to inform and influence in-
ternal decision-making. This approach was chosen
above other systematic approaches, such as the Child
Health and Nutrition Research Initiative method [12],
since it was felt that such approaches as well as
Delphi methodologies tend to focus on expert views,
which, while important, negate the inclusion of a
wider public stakeholder base, who also have legitim-
ate and important insights into research priorities.
The consultation results provide a valuable insight to
both donors and researchers to help direct the long-
term development of their respective research portfolios.
It also adds to the knowledge base regarding approaches
to integrate evidence into policy and practice, and to
build research capacity in low-resource settings.
The consultation identified NCDs as the most import-
ant research priority for the long-term future. This cor-
relates with the developing burden of disease globally,
which shows increasing morbidity and mortality from
NCDs in low- and middle-income countries [2, 13],
often affecting the poorest people living in low-resource
settings [14, 15]. However, there are still many gaps in
the evidence base for NCDs in low-resource settings,
particularly regarding risk-factors for disease, and which
populations are most susceptible [15]. It should also be
acknowledged that there is a shifting discourse in global
health which recognises the growing importance of
NCDs. This is reflected in their prominence in the
Global Goals [4] and the development of the World
Health Organization Global Action Plan for the Preven-
tion and Control of NCDs [16].
Infectious diseases were identified as both an import-
ant theme for future research but also an area to be re-
duced. This may reflect the recognition of progress
made in reducing the burden of infectious disease, and
an increasing need to focus on other areas [17]. It could
also suggest support for a change in approach to infec-
tious disease research from population wide methods, to
concentrating on accessing hard to reach groups and
emerging threats. This suggests an important realisation
from participants that the important agenda of infectious
disease has not been dealt with [10, 18, 19], although
there are new emerging threats that should not be over-
looked as funders prioritise future investments. Owing
to the already very high priority and associated funding
given to infectious diseases, it is possibly not surprising
that respondents felt this was going to be less important
in the future. Nevertheless, this does not preclude sup-
port for further investment to consolidate and advance
research progress made in this field. The outcomes from
the survey regarding increasing and reducing priorities
highlight the growing issue of a double burden of disease
for infectious diseases and NCDs, which has a stronger
impact on the poorest in low-resource settings [20–22].
For research to have a positive effect in low-resource
settings, research funding must be based on target coun-
try need [23–26]. However, research priorities globally
are often based on the requirements of international
donor organisations, rather than the recipient countries
[25–27]. This potentially leads to research which does
not meet the needs of target populations, and where the
knowledge generated is not incorporated into policy or
practice [28–30]. The results from the consultation sup-
port this position, calling for research funding to be
based on country need, and to be designed and delivered
by the stakeholders in the country of interest.
Our consultation findings also emphasised the import-
ance of early and meaningful engagement of stakeholders
in the research process to facilitate effective research
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uptake. This has to go further than signing up a pol-
icymaker to support a research proposal; the key
stakeholders must be given influence over the topic
selection, research process and outcome implementa-
tion. International funding based on the requirements
of international donors, rather than the priorities of
countries, reduces the impact of research outcomes at
a country level [29].
Research capacity building in low- and middle-income
countries is essential if solutions to key health issues in
low-resource countries are to be progressed [6], although
this is a challenging task. Capacity building support for in-
dividuals (from a range of backgrounds) was recognised as
being key to developing this area in low-resource settings
in the consultation responses. Collaboration and partner-
ship was noted as being an important vehicle for this, with
particular attention given to North–South institution part-
nerships. Donors have a responsibility to ensure that
research funding places research capacity building as
central in funding decision criteria. This requires a more
holistic approach, which works at the individual, institu-
tional and the wider research environment [6].
There are limitations in the process and outcomes of
the consultation survey. The opportunistic nature of the
survey’s dissemination means the findings presented here
may not be representative of the full range of stakeholders
or views. Additionally, since the consultation was initially
distributed by DfID, this may have resulted in a higher
response rate from organisations and individuals already
affiliated with DfID and may in turn have resulted in re-
sponses more in line with current DfID funding priorities
and thinking. This was addressed in the wider consult-
ation process, which also included opportunities for
targeted feedback. This helped to ensure that opinion
from outside of the established DfID relationships could
be considered. It should also be noted that the variety of
responses in the public consultation, and comparison
against current DfID research funding allocations, sug-
gests that respondents represented a far wider spectrum
of stakeholders than those who were initially targeted for
dissemination of the survey. The terminology used in the
consultation questions enquiring to future research prior-
ities uses the terminology ‘global health research’; the
authors were keen to ensure as wide a breath of response
as possible, but also acknowledge that this terminology
may have resulted in quite generic responses. Finally, the
thematic analysis will inevitably reflect the values and
judgements of the investigators, and the interpretations
they have made during and following the process of data
analysis. However, by using a systematic and established
approach for data analysis, we hope to have reduced in-
herent bias. Publication of the results also gives other
stakeholders the opportunity to present reflections on our
interpretation, and to present their own interpretation.
Conclusions
The above limitations notwithstanding, our view is that
these findings, taken together with other sources of
qualitative and quantitative information, including those
informing the wider consultation, provides valuable in-
sights into how DfID stakeholders prioritise research. The
outcomes from this consultation survey have been
reviewed alongside the outcomes from the other elements
of the consultation to inform the research funding prior-
ities of DfID and wider United Kingdom development
funding for global health research [11]. It also provides a
useful insight to funders, researchers and research imple-
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